Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Navigating Emerging Biomarkers in MS Care
Ethan Meltzer, MD
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Uncovering TK2d: How to Navigate Diagnostic Challenges
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Immunologic Phenotyping: The Future of Personalized MG Care
A Closer Look at the Biology Behind MS Progression
Exploring Genetic Links Between EBV Clearance and MS Risk
Discharge Planning After Myasthenic Crisis
More Than a Myopathy: The Lived Experience of TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.